Trial intelligence / Profile preview

N-acetylcysteine for fibrocystic breast changes in overweight or obese women

IRCT20170513033941N69Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Mastopathy comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: hs-CRP. Started Feb 2020; status: completed.

02

Drugs

acetylcysteine
03

Conditions

Mastopathy

Beyond the preview

Go deeper on IRCT20170513033941N69.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170513033941N69.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call